News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zonagen (ZONA) Effects Name Change To Repros Therapeutics Inc. (RPRX)


5/3/2006 2:42:24 PM

THE WOODLANDS, Texas--(BUSINESS WIRE)--May 2, 2006--Zonagen, Inc. (Nasdaq:ZONA - News; PCX:ZONA - News) today announced that it has effected its name change from Zonagen, Inc. to Repros Therapeutics Inc. The name change was approved by the Company's shareholders at the Company's annual meeting today, May 2, 2006. In conjunction with the name change, the Company also is changing its common stock ticker symbol on The Nasdaq Capital Market and the Pacific Exchange to "RPRX", commencing with the opening of trading on May 4, 2006. Along with the name and ticker symbol changes, the Company's common stock has a new CUSIP number, 76028H 10 0. Stockholders are not required to take any action with respect to the name change; however, any stockholder wishing to exchange a paper stock certificate for a new one bearing the new name may contact the Company's Chief Financial Officer at (281) 719-3400 for information and instructions.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES